Breaking News Instant updates and real-time market news.

NOVS

Novus Capital Corp.

$10.95 /

+0.14 (+1.30%)

08:56
10/21/20
10/21
08:56
10/21/20
08:56

AppHarvest opens high-tech greenhouse in Appalachia

AppHarvest announced the opening of its 2.76-million-square-foot high-tech greenhouse in Appalachia. The Morehead, KY facility is the first of a series designed to redefine American agriculture by growing non-GMO, chemical pesticide-free fruits and vegetables closer to the people eating them. The company and its mission represent a stark change to the existing American food system, which is increasingly reliant on imports. AppHarvest's first harvest of tomatoes is expected to be available in early 2021 at leading grocers and restaurants. Tomatoes are AppHarvest's first crop as more than 60% of America's fresh tomatoes were imported in 2019, an increase of almost 50% over the past decade. AppHarvest expects to create more than 300 jobs at its Morehead farm in Appalachia, which has long trailed national employment trends due to the decline of the coal industry. In just over two years, AppHarvest attracted more than $150M in investment into the region and announced on September 29 a definitive agreement for a business combination with publicly traded special purpose acquisition company Novus Capital. The combination, which is expected to close late in the fourth quarter of 2020 or early in the first quarter of 2021, will provide $475 million of gross proceeds to the company, including $375M fully committed common stock PIPE at $10.00 per share anchored by existing and new investors - including Fidelity Management & Research Company, LLC, Inclusive Capital, and Novus Capital Corporation.

TODAY'S FREE FLY STORIES

Hot Stocks
Nu Skin reports on environmental impact of its top products » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
NUS

Nu Skin

$57.79 /

+2.16 (+3.88%)

Nu Skin reported it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

11/05/20 Deutsche Bank
Nu Skin price target raised to $57 from $49 at Deutsche Bank
10/02/20 DA Davidson
Nu Skin price target raised to $68 from $61 at DA Davidson
10/02/20 BofA
Nu Skin upgraded to Neutral from Underperform at BofA
10/02/20 BofA
Nu Skin upgraded to Neutral from Underperform at BofA
NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

Initiation
Checkpoint Therapeutics initiated with an Overweight at Cantor Fitzgerald » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
CKPT

Checkpoint Therapeutics

$3.31 /

-0.045 (-1.34%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

09/29/20 H.C. Wainwright
Checkpoint Therapeutics price target raised to $17 from $15 at H.C. Wainwright
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
04/13/20 B. Riley FBR
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

  • 18
    Sep
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

Earnings
J.B. Hunt reports Q4 EPS $1.44, consensus $1.30 » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
JBHT

J.B. Hunt

$148.42 /

-3.23 (-2.13%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

Hot Stocks
Netflix says 'very close to being sustainably FCF positive' » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
NFLX

Netflix

$500.52 /

+2.57 (+0.52%)

Netflix said: "We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

Hot Stocks
PACCAR, Aurora form strategic partnership over autonomous trucks » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
PCAR

Paccar

$89.22 /

+1 (+1.13%)

PACCAR and Aurora have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCAR Paccar
$89.22 /

+1 (+1.13%)

PCAR Paccar
$89.22 /

+1 (+1.13%)

01/13/21 Deutsche Bank
Paccar named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/07/21 Wolfe Research
Paccar downgraded to Underperform from Peer Perform at Wolfe Research
12/28/20 Barclays
Rising steel prices possible headwind for machinery companies, says Barclays
12/15/20 Morgan Stanley
Paccar upgraded to Equal Weight on expected Class 8 recovery at Morgan Stanley
PCAR Paccar
$89.22 /

+1 (+1.13%)

PCAR Paccar
$89.22 /

+1 (+1.13%)

Syndicate
AcelRx announces offering of common stock, no amount given » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
ACRX

AcelRx

$2.36 /

+0.29 (+14.01%)

Cantor Fitzgerald &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
07/20/20 Credit Suisse
AcelRx downgraded to Underperform from Neutral at Credit Suisse
ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

Syndicate
Editas Medicine files to sell 3.5M shares common stock » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
EDIT

Editas Medicine

$71.66 /

-4.42 (-5.81%)

J.P. Morgan and Morgan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

07:41 Today Morgan Stanley
Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley
01/13/21 Wells Fargo
Editas Medicine price target raised to $86 from $69 at Wells Fargo
01/08/21 Raymond James
Editas downgraded to Market Perform at Raymond James (Thursday morning)
01/07/21 Raymond James
Editas Medicine downgraded to Market Perform from Outperform at Raymond James
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

  • 24
    Jun
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

Hot Stocks
Netflix now targets 20% operating margin in FY21 » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
NFLX

Netflix

$500.56 /

+2.61 (+0.52%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

Hot Stocks
RF Industries promotes Peter Yin to CFO » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
RFIL

RF Industries

$5.11 /

-0.01 (-0.20%)

RF Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RFIL RF Industries
$5.11 /

-0.01 (-0.20%)

12/18/20 B. Riley Securities
RF Industries price target raised to $6.75 from $6.25 at B. Riley Securities
03/03/20
LD Micro to hold a virtual conference
01/29/20 B. Riley FBR
B. Riley FBR starts 'under the radar' RF Industries with Buy rating
01/29/20 B. Riley FBR
RF Industries initiated with a Buy at B. Riley FBR
Recommendations
Fate Therapeutics price target raised to $135 from $70 at Oppenheimer » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
FATE

Fate Therapeutics

$113.88 /

+0.38 (+0.33%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

01/15/21 Barclays
Fate Therapeutics price target raised to $130 from $110 at Barclays
12/21/20 Stifel
Fate Therapeutics price target raised to $118 from $79 at Stifel
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
12/17/20 Barclays
Fate Therapeutics price target raised to $110 from $80 at Barclays
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

  • 06
    Jan
  • 09
    Jun
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

Hot Stocks
BridgeBio and Eidos' stockholders approve acquisition » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
BBIO

BridgeBio

$69.23 /

+0.62 (+0.90%)

, EIDX

Eidos Therapeutics

$127.90 /

+1.37 (+1.08%)

BridgeBio Pharma (BBIO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

01/11/21 H.C. Wainwright
BridgeBio price target raised to $87 from $64 at H.C. Wainwright
12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
12/14/20 BTIG
BridgeBio price target raised to $91 from $49 at BTIG
12/10/20 H.C. Wainwright
BridgeBio price target raised to $64 from $53 at H.C. Wainwright
EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
11/18/20 BTIG
Eidos Therapeutics downgraded to Neutral from Buy at BTIG
10/12/20 H.C. Wainwright
BridgeBio price target raised to $53 from $50 at H.C. Wainwright
10/07/20
Fly Intel: Top five analyst downgrades
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

  • 29
    May
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

Earnings
Perion Network sees Q4 EPS 35c-36, consensus 23c » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
PERI

Perion Network

$13.92 /

+0.91 (+6.99%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$13.92 /

+0.91 (+6.99%)

PERI Perion Network
$13.92 /

+0.91 (+6.99%)

01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Roth Capital
Perion Network initiated with a Buy at Roth Capital
PERI Perion Network
$13.92 /

+0.91 (+6.99%)

PERI Perion Network
$13.92 /

+0.91 (+6.99%)

Hot Stocks
Netflix up 7% after Q4 results, Q1 guidance » 16:04
01/19/21
01/19
16:04
01/19/21
16:04
NFLX

Netflix

$500.78 /

+2.83 (+0.57%)

Shares of Netflix are up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

Hot Stocks
Netflix sees Q1 global streaming paid net additions of 6.0M » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
NFLX

Netflix

$501.02 /

+3.07 (+0.62%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

Hot Stocks
Echo Global appoints Brian Parchem as Chief Information Officer » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
ECHO

Echo Global

$27.34 /

+0.24 (+0.89%)

Echo Global Logistics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
11/06/20 Barrington
Echo Global price target raised to $36 from $30 at Barrington
07/24/20 Barrington
Echo Global price target raised to $30 from $22 at Barrington
07/17/20 SunTrust
SunTrust raises price targets in select Trucking/Logistics names
ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

Earnings
Nicolet Bankshares reports Q4 EPS $1.74, consensus $1.49  16:03
01/19/21
01/19
16:03
01/19/21
16:03
NCBS

Nicolet Bankshares

$71.90 /

-0.39 (-0.54%)

 
ShowHide Related Items >><<
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

10/23/20 Maxim
Nicolet Bankshares price target raised to $77 from $70 at Maxim
10/09/20 Stephens
Stephens starts Nicolet Bankshares at Equal Weight, citing valuation
10/09/20 Stephens
Nicolet Bankshares initiated with an Equal Weight at Stephens
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

Earnings
Interactive Brokers reports Q4 adjusted EPS 69c, consensus 59c » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
IBKR

Interactive Brokers

$69.75 /

+0.68 (+0.98%)

Reports Q4 revenue $599M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

01/05/21 Compass Point
Interactive Brokers price target raised to $65 from $62 at Compass Point
01/04/21 Goldman Sachs
Interactive Brokers growth still firing on all cylinders, says Goldman Sachs
12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 Compass Point
Interactive Brokers upgraded to Buy with $62 price target at Compass Point
IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

Earnings
Netflix sees Q1 EPS $2.97, consensus $2.10 » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
NFLX

Netflix

$501.84 /

+3.89 (+0.78%)

Sees Q1 revenue $7.13B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

Syndicate
Syros Pharmaceuticals files to sell common stock, no amount given » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
SYRS

Syros Pharmaceuticals

$14.91 /

+0.8 (+5.67%)

Cowen and Piper Sandler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

11/10/20 Brookline
Syros Pharmaceuticals initiated with a Buy at Brookline
11/05/20 Roth Capital
Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital
11/04/20
Fly Intel: Top five analyst upgrades
11/04/20 H.C. Wainwright
Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright
SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

Hot Stocks
Netflix reports Q4 global streaming paid net additions of 8.51M » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
NFLX

Netflix

$501.84 /

+3.89 (+0.78%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

Syndicate
Perion Network files to sell $50M in common stock » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
PERI

Perion Network

$13.87 /

+0.855 (+6.57%)

Oppenheimer & Co.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$13.87 /

+0.855 (+6.57%)

PERI Perion Network
$13.87 /

+0.855 (+6.57%)

01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Roth Capital
Perion Network initiated with a Buy at Roth Capital
PERI Perion Network
$13.87 /

+0.855 (+6.57%)

PERI Perion Network
$13.87 /

+0.855 (+6.57%)

Syndicate
Fulcrum Therapeutics files to sell common stock, no amount given » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
FULC

Fulcrum Therapeutics

$11.78 /

+0.84 (+7.68%)

SVB Leerink, Piper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

Syndicate
Aclaris Therapeutics files to sell common stock, no amount given » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
ACRS

Aclaris Therapeutics

$18.23 /

+12.37 (+211.09%)

Cantor Fitzgerald &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

12:01 Today William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

Earnings
Netflix reports Q4 EPS $1.19, consensus $1.39 » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
NFLX

Netflix

$502.50 /

+4.55 (+0.91%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

Periodicals
Facebook has no plans to lift Trump's account suspension, NBC News says » 15:49
01/19/21
01/19
15:49
01/19/21
15:49
FB

Facebook

$261.73 /

+10.2 (+4.06%)

Facebook does not have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
09:52 Today
Fly Intel: Top five analyst upgrades
07:28 Today KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.